Published • loading... • Updated
SCG Cell Therapy Announces Clearance of Investigational New Drug Application by the China NMPA for SCG101V
Summary by Watauga Democrat
33 Articles
33 Articles
keenesentinel.com+32 Reposted by 32 other sources
SCG Cell Therapy Announces Clearance of Investigational New Drug Application by the China NMPA for SCG101V
SINGAPORE, July 7, 2025 /PRNewswire/ -- SCG Cell Therapy Pte Ltd (SCG), a clinical-stage biotechnology company pioneering TCR T cell therapy for infectious diseases and associated cancers, announced today that the China National Medical Products Administration (NMPA) has cleared the…
Coverage Details
Total News Sources33
Leaning Left5Leaning Right4Center16Last UpdatedBias Distribution64% Center
Bias Distribution
- 64% of the sources are Center
64% Center
L 20%
C 64%
R 16%
Factuality
To view factuality data please Upgrade to Premium
